|Bid||8,474.00 x 0|
|Ask||8,475.00 x 0|
|Day's range||8,440.00 - 8,525.00|
|52-week range||6,499.80 - 8,923.00|
|Beta (5Y monthly)||0.24|
|PE ratio (TTM)||38.37|
|Earnings date||29 Jul 2021|
|Forward dividend & yield||2.07 (2.44%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||78.83|
AstraZeneca Plc is "scouring" its global supply chain to try and boost COVID-19 vaccine supplies to Thailand and Southeast Asia, its representative for the country said on Saturday, amidst speculations of local production shortfalls. The comments come after leaked letters https://www.reuters.com/business/healthcare-pharmaceuticals/leaked-letters-show-astrazeneca-vaccine-commitment-not-thailand-claimed-2021-07-19 showed last week that the drugmaker had offered to supply 5-6 million vaccine doses a month to Thailand, contradicting assertions by Thai officials that the government is owed 10 million a month and 61 million doses by end-2021. AstraZeneca is "scouring the 20+ supply chains in our worldwide manufacturing network to find additional vaccines for Southeast Asia, including Thailand", James Teague, managing director of AstraZeneca Thailand, said in a statement.
(Bloomberg) -- AstraZeneca Plc is planning to import Covid-19 vaccines to Southeast Asia as its only manufacturing facility in the region struggles to ramp up output to meet demand from countries hit hard by the delta variant.The Anglo-Swedish drugmaker is scouring more than 20 supply chains in its global manufacturing network to find additional vaccines for Southeast Asia, including Thailand, James Teague, managing director for AstraZeneca Thailand, said in an open letter Saturday. The company
Dr. Shikha Jain, Assistant Professor of Medicine, University of Illinois Chicago, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.